*By Bridgette Webb and Amanda Weston* Tesla's board is going ahead with its review of Elon Musk’s gambit to take the company private, though there's still lots of skepticism around the deal and its various backers. "We still don't know who the backer is and what the deal structure will end up looking like," said Christian Prenzler, vice president of business development at Teslarati. "I definitely wouldn't bet against the deal's existence or the gravity it brings to what we know as Tesla on the NASDAQ." Musk's plan, announced on Twitter on Tuesday, would take the electric carmaker private at a price of $420 a share. He's argued that Tesla would be less disruptive as a private company. It would also allow the company to escape the glaring spotlight of fluctuating stock prices, mounting questions on model 3 production goals and quarterly reports. Investors may see an upside in such a move, according to Prenzler, and a number of potential backers have been rumored, including the Saudi Wealth Fund, Tencent and Softbank. "It’s being pitched like an investment in a company like Uber," Prenzler said. "It’s a long-term plan. They’re betting on Musk making a million cars in a year. " Still, Prenzler sees value in keeping Tesla public. "It’s very healthy for a company to be public, to be under the public eye, to have a lot of accountability. And to be forced into really revealing a lot of information and going into some of these rough times," Prenzler said. Jason Moser, an analyst at The Motley Fool, said in a separate interview with Cheddar that Musk's ambitions require "extremely long-term thinking," and may be more suitable for a private company. "In order to be as successful as possible, I think he would rather be able to run this business without being held to sort of arbitrary guidelines perhaps that Wall Street throws out there on a quarterly basis," Moser said. SpaceX, another one of Musk's companies, has been able to function out of the spotlight, allowing Musk to execute long-term planning. "With Tesla, I love what he's doing. I think the world needs more of what they're doing, and I think that getting out of the public scrutiny and public markets would probably give him the best opportunity to go ahead and execute that," Moser said. Like Prenzler, Moser thinks that Musk will get his way, eventually. "When he wants something, he can get it because he's relentless," said Moser. "He keeps at it until he figures out a way, so if he really wants to take this business private, and it sounds like he does, I don't think he's going to have a problem getting there." For more on this story, [click here](https://cheddar.com/videos/the-next-era-for-tesla).

Share:
More In Technology
Dan Ives Says Look Past Apple's Supply Warning as Demand Remains High
Apple warned of a potential $8 billion future sales hit due to supply issues, but Dan Ives, the managing director of equity research at Wedbush Securities, noted that the record quarterly report the tech giant posted shows demand remains high for Apple products and services. Ives joined Cheddar to explain why investors should look past the warning. "In these types of markets where many are yelling fire in a crowded theater, you look at the demand trends because that continues to be the focus for Apple," he said "I think you combine that with the services. I view it as a defensive name. It's a Rock of Gibraltar stock in a Category 5 storm as well as also an offensive play as I believe we start to move out of some of these just brutal headwinds that we've been seeing in the market once the Fed rips the band-aid off."
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Technological Breakthrough in Head Injury Prevention
Dr. Michael Bottlang and Dr. Steve Madey, co-founders of WaveCel, join Cheddar Innovates to share their breakthrough in hard hat design that could have ramifications for protecting against head trauma across industries.
Load More